Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study.
Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Dhillon N, Irvine MA, Reicherz F, O'Reilly C, Sediqi S, Xu RY, Razzaghian HR, Sadarangani M, Coombs D, O'Brien SF, Lavoie PM. Goldfarb DM, et al. Among authors: xu ry. BMJ Open. 2022 Apr 5;12(4):e057846. doi: 10.1136/bmjopen-2021-057846. BMJ Open. 2022. PMID: 35383082 Free PMC article.
Respiratory syncytial virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada: a retrospective observational study.
Viñeta Paramo M, Ngo LPL, Abu-Raya B, Reicherz F, Xu RY, Bone JN, Srigley JA, Solimano A, Goldfarb DM, Skowronski DM, Lavoie PM. Viñeta Paramo M, et al. Among authors: xu ry. Lancet Reg Health Am. 2023 Aug 30;25:100582. doi: 10.1016/j.lana.2023.100582. eCollection 2023 Sep. Lancet Reg Health Am. 2023. PMID: 37705884 Free PMC article.
DDIT4L regulates mitochondrial and innate immune activities in early life.
Michalski C, Cheung C, Oh JH, Ackermann E, Popescu CR, Archambault AS, Prusinkiewicz MA, Da Silva R, Majdoubi A, Viñeta Paramo M, Xu RY, Reicherz F, Patterson AE, Golding L, Sharma AA, Lim CJ, Orban PC, Klein Geltink RI, Lavoie PM. Michalski C, et al. Among authors: xu ry. JCI Insight. 2024 Feb 6;9(5):e172312. doi: 10.1172/jci.insight.172312. JCI Insight. 2024. PMID: 38319716 Free PMC article.
Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma patients after neoadjuvant chemoimmunotherapy and surgery: a multi-center propensity score match study.
Xie SH, Yang LT, Zhang H, Tang ZL, Lin ZW, Chen Y, Hong ZN, Xu RY, Lin WL, Kang MQ. Xie SH, et al. Among authors: xu ry. Front Immunol. 2024 Feb 5;15:1332492. doi: 10.3389/fimmu.2024.1332492. eCollection 2024. Front Immunol. 2024. PMID: 38375480 Free PMC article.
128 results